Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy
Sean Bujarski, Kyle A. Udd, Camilia Soof, Haiming Chen, Tanya M. Spektor, Tahmineh Safaie, Mingjie Li, Joshua A. Stern, Cathy Wang, Ning Xu, Marsiye Emamy‐Sadr, Regina A. Swift, Ashkon Rahbari, Saurabh Patil, Eric Souther, Bernard Regidor, Christine Sutanto, James R. Berenson
Topics & Concepts
MedicineInternal medicineMultiple myelomaProportional hazards modelQuartileHazard ratioProgression-free survivalGastroenterologyRefractory (planetary science)Survival analysisOncologyOverall survivalConfidence intervalAstrobiologyPhysicsMultiple Myeloma Research and TreatmentsRadiopharmaceutical Chemistry and ApplicationsLymphoma Diagnosis and Treatment